- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01406626
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care (LINK LA)
Study Overview
Detailed Description
The proposed study has two Primary Specific Aims:
- To examine individual-level and structural-level barriers to HIV care after release from jail, using formative semi-structured interviews with ex-inmates, case managers, and HIV care providers; and to use the information we obtain to inform the adaptation and tailoring of an intervention designed to improve linkage with and retention to HIV care for HIV+ ex-inmates (Complete);
- Using a two-group experimental RCT design, to test the adapted peer navigation intervention condition for HIV+ inmates upon release from jail compared to a usual care condition, and to evaluate the intervention's effectiveness at improving linkage with and retention in HIV care, self-reported ART adherence, and HIV RNA viral load suppression;
The intervention is hypothesized to result in greater linkage to care, a greater proportion completing at least three HIV care visits per year, increased self-reported ART adherence, and decreased levels of HIV RNA viral load compared to the usual care control group.
Secondary Aims of the study include assessing the potential moderating effects of substance abuse, the potential mediating effects of substance abuse treatment, and the program's effects on recidivism, and costs.
Active substance abuse is hypothesized to moderate the effect of the intervention, such that the intervention will be less effective among participants who report substance use.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90012
- LA County Jail
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Age 18 or older
- Men or TGW diagnosed HIV-positive
- English or bilingual Spanish speaking
- Selected for the TCM program (control condition) prior to LINK LA enrollment
- Residing in LA County upon release
- Eligible for ART or incarcerated on ART.
Exclusion criteria:
- Inability to give informed consent
- Parole hold or planned transfer to prison
- Stay in jail <5 days.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Peer Navigation Intervention Arm
Subjects will receive the following peer navigation services: 1) 10 Navigator meetings: Navigators will meet with participants in person to teach linkage/retention skills and knowledge 2a) 2 Navigator accompaniment sessions: the peer navigator will accompany participants to HIV care appointment. Before and after the appointment, participants and navigators will review linkage and retention skills/knowledge and things that make it hard or easy for him/her to get regular HIV care 2b) Optional peer navigator accompaniment sessions: If the participant requests, the peer navigator will provide accompaniment to supportive HIV care appointments (one per month max) 3) 14 peer navigator care calls: During these calls, navigators and participants will talk about any problems that could make it difficult to get regular HIV care. |
Peer navigation intervention to improve linkage to and retention in HIV care and suppress viral load for underserved HIV+ persons in Los Angeles
|
|
No Intervention: Usual Care
Participants assigned to the control arm will receive the transitional case management (TCM) services that are currently offered at the jail
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Linkage to HIV Care
Time Frame: 12 months
|
Number of HIV+ ex jail inmates accessing HIV care
|
12 months
|
|
Retention in Treatment
Time Frame: 12 months
|
This assesses whether or not the HIV+ ex jail inmates were retained in their HIV care after first accessing care.
|
12 months
|
|
Adherence to Treatment
Time Frame: 12 months
|
How adherent the HIV+ ex jail inmates are to their treatment regiment, by self-report.
|
12 months
|
|
Viral Load
Time Frame: 12 months
|
HIV+ ex jail inmates' viral load
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Costs
Time Frame: 12 months
|
Cost of the intervention and HIV care
|
12 months
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- R01DA030781 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV-infection/Aids
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
Merck Sharp & Dohme LLCHIV Vaccine Trials NetworkTerminatedHIV Infections | AIDS
-
Peking Union Medical CollegeUnknown
-
ANRS, Emerging Infectious DiseasesPfizerCompleted
-
Peking Union Medical CollegeMinistry of Science and Technology of the People´s Republic of ChinaUnknownAIDS/HIV PROBLEMChina
-
New York UniversityNYU Langone HealthUnknownHIV-infection/AIDSUnited States
-
Tobira Therapeutics, Inc.ViiV HealthcareCompletedHIV-infection/AIDSUnited States
-
Peking Union Medical College HospitalCompleted
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Imperial College LondonBill and Melinda Gates Foundation; University of Oxford; Rockefeller UniversityRecruitingHIV/AIDS and InfectionsDenmark, United Kingdom
Clinical Trials on Peer Navigator
-
Illinois Institute of TechnologyPatient-Centered Outcomes Research Institute; TrilogyCompletedMental DisordersUnited States
-
University of California, Los AngelesCompleted
-
University of California, Los AngelesNot yet recruiting
-
Children's National Research InstitutePatient-Centered Outcomes Research InstituteCompletedPremature Birth of Newborn | Newborn Morbidity | Family | Immature Newborn | Infant Newborn DiseaseUnited States
-
Illinois Institute of TechnologyNational Institute on Minority Health and Health Disparities (NIMHD); ACCESS... and other collaboratorsCompletedObesity | Mental DisorderUnited States
-
Rhode Island HospitalBrown UniversityCompletedOpioid-Related Disorders | Opioid Dependence | Opioid Use | Opioid AbuseUnited States
-
Fenway Community HealthHarvard UniversityCompletedPre-Exposure ProphylaxisUnited States
-
Wake Forest University Health SciencesNot yet recruitingHuman Immunodeficiency VirusUnited States
-
Massachusetts General HospitalUnited States Department of DefenseRecruitingNeurofibromatosis 1United States
-
University of Illinois at ChicagoPatient-Centered Outcomes Research Institute; American Heart Association; University... and other collaboratorsCompletedMyocardial Infarction | Heart Failure | Pneumonia | Chronic Obstructive Pulmonary Disease | Sickle Cell DiseaseUnited States